CSL (CSL AT)

Analysis

Health Care • United States

CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.

Refresh

bullish•CSL Ltd

•05 Aug 2026 02:03

Primer: CSL Ltd (CSL AU) - Aug 2026

CSL is a global biotechnology leader with a dominant position in the plasma-derived therapies market, a significant presence in the influenza...

αSK Primers

111 Views

bullish•CSL

•18 Feb 2026 11:07

Primer: CSL (CSL AT) - Feb 2026

CSL is a global biotechnology leader with a dominant position in plasma-derived therapies (CSL Behring) and a significant presence in the...

αSK Primers

156 Views

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00